Octapharma AG
Seidenstraße 2
Lachen
CH-8853
Tel: 41-55-451-2121
Fax: 41-55-451-2110
Website: http://www.octapharma.com/content/
Email: kbjoernstrup@octapharma.ch
82 articles about Octapharma AG
-
Octapharma AG Update: Product Withdrawal/Product Recall - Octagam(R)
9/24/2010
-
Octapharma AG Release: The Next-Generation VWF/FVIII Concentrate, Wilate(R), Strives to Reflect the Normal Physiological Condition
9/16/2010
-
Octapharma AG’s Drive to Prevent and Eradicate FVIII Antibody Inhibitors in Haemophilia Treatment
9/13/2010
-
New Octapharma AG 10% High Purity Immunoglobulin Enters Phase II/III Study in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
9/8/2010
-
Octapharma AG Release: Uniplas(R) Clinical Development Successfully Completed
8/26/2010
-
Octapharma AG Trial on Intravenous Immunoglobulin (IVIG) in Alzheimer's Disease at ICAD 2010 Congress
4/19/2010
-
Octapharma AG Results 2009
3/22/2010
-
Octapharma AG: New High Purity Immunoglobulin Enters Phase III in Europe and the US
2/16/2010
-
Octapharma AG Receives Orphan Drug Exclusivity Approval for wilate(R)
1/13/2010
-
Octapharma AG Announces Second Quarter 2009 Results and Mid Term Outlook of the Market
10/5/2009
-
Octapharma AG Provides ProMetic BioSciences, Inc. With a $4.5 M Advance on a Long-Term Supply Agreement
10/1/2009
-
Octapharma AG Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
8/26/2009
-
Octapharma AG Targeting the Major Risk of Hemophilia Treatment
8/26/2009
-
Octapharma AG Announces First-Ever Research Grants Program, Demonstrating Commitment to Cutting-Edge Clinical Research
3/30/2009
-
Octapharma AG Names Dennis D. Curtin To Lead U.S. Plasma Operations
12/5/2008
-
Octapharma AG Agrees to Acquire 33 Plasma Centers Throughout the U.S.
8/5/2008
-
ProMetic Life Sciences Inc. Announces Octapharma AG Publication of PRDT's Prion Removal Resin in Octaplas(R) Manufacturing Process
6/10/2008
-
ProMetic Life Sciences Inc. Announces Octapharma AG Publication of PRDT'S Prion Removal Resin in Octaplas(R)
6/10/2008
-
Haemonetics Corporation and Octapharma AG Announce Plasma Collection Technology Contract
5/30/2008
-
BAC and Octapharma AG to Develop Custom Ligand for Recombinant Plasma Protein
3/13/2008